Yebari M, Bouchaala A, Berraj I
Eur Heart J Case Rep. 2024; 8(11):ytae585.
PMID: 39545154
PMC: 11561561.
DOI: 10.1093/ehjcr/ytae585.
Rosca A, Vladareanu A, Mititelu A, Popescu B, Badiu C, Caruntu C
J Clin Med. 2021; 10(1).
PMID: 33406783
PMC: 7795962.
DOI: 10.3390/jcm10010147.
Cruz-Topete D, Dominic P, Stokes K
Redox Biol. 2020; 31:101490.
PMID: 32169396
PMC: 7212492.
DOI: 10.1016/j.redox.2020.101490.
Bianchi V
Heart Fail Rev. 2018; 23(5):773-788.
PMID: 29978359
DOI: 10.1007/s10741-018-9721-0.
Tostes R, Carneiro F, Carvalho M, Reckelhoff J
Am J Physiol Regul Integr Comp Physiol. 2015; 310(1):R1-14.
PMID: 26538238
PMC: 4796634.
DOI: 10.1152/ajpregu.00392.2014.
Androgenic anabolic steroid, cocaine and amphetamine abuse and adverse cardiovascular effects.
Martinez-Quintana E, Saiz-Udaeta B, Marrero-Negrin N, Lopez-Merida X, Rodriguez-Gonzalez F, Nieto-Lago V
Int J Endocrinol Metab. 2014; 11(4):e8755.
PMID: 24719633
PMC: 3968994.
DOI: 10.5812/ijem.8755.
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.
Pope Jr H, Wood R, Rogol A, Nyberg F, Bowers L, Bhasin S
Endocr Rev. 2014; 35(3):341-75.
PMID: 24423981
PMC: 4026349.
DOI: 10.1210/er.2013-1058.
Testosterone and secondary hypertension: new pieces to the puzzle.
Barton M, Prossnitz E, Meyer M
Hypertension. 2012; 59(6):1101-3.
PMID: 22566501
PMC: 3647368.
DOI: 10.1161/HYPERTENSIONAHA.112.195149.
A case of late stent thrombosis following platelet transfusion in a patient with aplastic anemia.
Shin H, Kang T
Korean Circ J. 2012; 42(1):54-7.
PMID: 22363385
PMC: 3283756.
DOI: 10.4070/kcj.2012.42.1.54.
Anabolic steroids and cardiovascular risk.
Angell P, Chester N, Green D, Somauroo J, Whyte G, George K
Sports Med. 2012; 42(2):119-34.
PMID: 22229259
DOI: 10.2165/11598060-000000000-00000.
Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.
Achar S, Rostamian A, Narayan S
Am J Cardiol. 2010; 106(6):893-901.
PMID: 20816133
PMC: 4111565.
DOI: 10.1016/j.amjcard.2010.05.013.
Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction.
Baggish A, Weiner R, Kanayama G, Hudson J, Picard M, Hutter Jr A
Circ Heart Fail. 2010; 3(4):472-6.
PMID: 20424234
PMC: 2909423.
DOI: 10.1161/CIRCHEARTFAILURE.109.931063.
Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?.
Kanayama G, Hudson J, Pope Jr H
Drug Alcohol Depend. 2008; 98(1-2):1-12.
PMID: 18599224
PMC: 2646607.
DOI: 10.1016/j.drugalcdep.2008.05.004.
Homocysteine induced cardiovascular events: a consequence of long term anabolic-androgenic steroid (AAS) abuse.
Graham M, Grace F, Boobier W, Hullin D, Kicman A, Cowan D
Br J Sports Med. 2006; 40(7):644-8.
PMID: 16488899
PMC: 2564318.
DOI: 10.1136/bjsm.2005.025668.
Behavioural manifestations of anabolic steroid use.
Trenton A, Currier G
CNS Drugs. 2005; 19(7):571-95.
PMID: 15984895
DOI: 10.2165/00023210-200519070-00002.
Cocaine induced myocardial infarction.
Inyang V, Cooper A, Hodgkinson D
J Accid Emerg Med. 1999; 16(5):374-5.
PMID: 10505926
PMC: 1347067.
DOI: 10.1136/emj.16.5.374.